Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariya S Liyasova

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2014
Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatmentMariya S Liyasova, Ke Ma, Stanley Lipkowitz
Biochemical Pharmacology|October 20, 2009
Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545Mariya S Liyasova, Lawrence M Schopfer, Oksana Lockridge
Chemical Research in Toxicology|July 17, 2012
Cresyl saligenin phosphate, an organophosphorus toxicant, makes covalent adducts with histidine, lysine, and tyrosine residues of human serum albuminMariya S Liyasova, Lawrence M Schopfer, Oksana Lockridge
Chemico-Biological Interactions|August 18, 2012
Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesteraseMariya S Liyasova, Lawrence M Schopfer, Oksana Lockridge
Chemical Research in Toxicology|February 16, 2013
Newly observed spontaneous activation of ethephon as a butyrylcholinesterase inhibitorMariya S Liyasova, Lawrence M Schopfer, Sean Kodani, et al.
Plos One|May 24, 2019
Cbl interacts with multiple E2s in vitro and in cellsMariya S Liyasova, Ke Ma, Donna Voeller, et al.
The Journal of Biological Chemistry|December 5, 2022
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growthDavid J Wisniewski, Mariya S Liyasova, Soumya Korrapati, et al.
Molecular Pharmaceutics|March 2, 2017
Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer CellsJohn S Schardt, Jinan M Oubaid, Sonya C Williams, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2014
Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatmentMariya S Liyasova, Ke Ma, Stanley Lipkowitz
Biochemical Pharmacology|October 20, 2009
Reaction of human albumin with aspirin in vitro: mass spectrometric identification of acetylated lysines 199, 402, 519, and 545Mariya S Liyasova, Lawrence M Schopfer, Oksana Lockridge
Chemical Research in Toxicology|July 17, 2012
Cresyl saligenin phosphate, an organophosphorus toxicant, makes covalent adducts with histidine, lysine, and tyrosine residues of human serum albuminMariya S Liyasova, Lawrence M Schopfer, Oksana Lockridge
Chemico-Biological Interactions|August 18, 2012
Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesteraseMariya S Liyasova, Lawrence M Schopfer, Oksana Lockridge
Chemical Research in Toxicology|February 16, 2013
Newly observed spontaneous activation of ethephon as a butyrylcholinesterase inhibitorMariya S Liyasova, Lawrence M Schopfer, Sean Kodani, et al.
Plos One|May 24, 2019
Cbl interacts with multiple E2s in vitro and in cellsMariya S Liyasova, Ke Ma, Donna Voeller, et al.
The Journal of Biological Chemistry|December 5, 2022
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growthDavid J Wisniewski, Mariya S Liyasova, Soumya Korrapati, et al.
Molecular Pharmaceutics|March 2, 2017
Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer CellsJohn S Schardt, Jinan M Oubaid, Sonya C Williams, et al.
Pageof 1